IRIS Accounts Production v24.3.2.46 07643110 director 1.7.23 30.6.24 30.6.24 false true false false true false Ordinary (A to D) 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh076431102023-06-30076431102024-06-30076431102023-07-012024-06-30076431102022-06-30076431102022-07-012023-06-30076431102023-06-3007643110ns15:EnglandWales2023-07-012024-06-3007643110ns14:PoundSterling2023-07-012024-06-3007643110ns10:Director12023-07-012024-06-3007643110ns10:PrivateLimitedCompanyLtd2023-07-012024-06-3007643110ns10:SmallEntities2023-07-012024-06-3007643110ns10:AuditExempt-NoAccountantsReport2023-07-012024-06-3007643110ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-06-3007643110ns10:SmallCompaniesRegimeForAccounts2023-07-012024-06-3007643110ns10:FullAccounts2023-07-012024-06-3007643110ns10:OrdinaryShareClass12023-07-012024-06-3007643110ns10:RegisteredOffice2023-07-012024-06-3007643110ns5:CurrentFinancialInstruments2024-06-3007643110ns5:CurrentFinancialInstruments2023-06-3007643110ns5:Non-currentFinancialInstruments2024-06-3007643110ns5:Non-currentFinancialInstruments2023-06-3007643110ns5:ShareCapital2024-06-3007643110ns5:ShareCapital2023-06-3007643110ns5:RetainedEarningsAccumulatedLosses2024-06-3007643110ns5:RetainedEarningsAccumulatedLosses2023-06-3007643110ns5:PlantMachinery2023-07-012024-06-3007643110ns5:FurnitureFittings2023-07-012024-06-3007643110ns5:MotorVehicles2023-07-012024-06-3007643110ns5:LeaseholdImprovements2023-06-3007643110ns5:PlantMachinery2023-06-3007643110ns5:FurnitureFittings2023-06-3007643110ns5:MotorVehicles2023-06-3007643110ns5:LeaseholdImprovements2023-07-012024-06-3007643110ns5:LeaseholdImprovements2024-06-3007643110ns5:PlantMachinery2024-06-3007643110ns5:FurnitureFittings2024-06-3007643110ns5:MotorVehicles2024-06-3007643110ns5:LeaseholdImprovements2023-06-3007643110ns5:PlantMachinery2023-06-3007643110ns5:FurnitureFittings2023-06-3007643110ns5:MotorVehicles2023-06-3007643110ns5:WithinOneYearns5:CurrentFinancialInstruments2024-06-3007643110ns5:WithinOneYearns5:CurrentFinancialInstruments2023-06-3007643110ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2024-06-3007643110ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2023-06-3007643110ns5:FinanceLeasesns5:WithinOneYearns5:CurrentFinancialInstruments2024-06-3007643110ns5:FinanceLeasesns5:WithinOneYearns5:CurrentFinancialInstruments2023-06-3007643110ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2024-06-3007643110ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2023-06-3007643110ns5:FinanceLeasesns5:BetweenOneFiveYears2024-06-3007643110ns5:FinanceLeasesns5:BetweenOneFiveYears2023-06-3007643110ns5:HirePurchaseContracts2024-06-3007643110ns5:HirePurchaseContracts2023-06-3007643110ns5:FinanceLeases2024-06-3007643110ns5:FinanceLeases2023-06-3007643110ns5:WithinOneYear2024-06-3007643110ns5:WithinOneYear2023-06-3007643110ns5:BetweenOneFiveYears2024-06-3007643110ns5:BetweenOneFiveYears2023-06-3007643110ns5:AllPeriods2024-06-3007643110ns5:AllPeriods2023-06-3007643110ns5:Secured2024-06-3007643110ns5:Secured2023-06-3007643110ns10:OrdinaryShareClass12024-06-30076431101ns10:Director12023-06-30076431101ns10:Director12022-06-30076431101ns10:Director12023-07-012024-06-30076431101ns10:Director12022-07-012023-06-30076431101ns10:Director12024-06-30076431101ns10:Director12023-06-30
REGISTERED NUMBER: 07643110 (England and Wales)











Unaudited Financial Statements

for the Year Ended 30 June 2024

for

Central Medical Services Ltd

Central Medical Services Ltd (Registered number: 07643110)

Contents of the Financial Statements
for the Year Ended 30 June 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Central Medical Services Ltd

Company Information
for the Year Ended 30 June 2024







DIRECTOR: S Wood





REGISTERED OFFICE: Unit 2 Park Place
Robey Close
Linby
Nottinghamshire
NG15 8AA





REGISTERED NUMBER: 07643110 (England and Wales)





ACCOUNTANTS: Mabe Allen LLP
Chartered Accountants
The Old Manse
29 St. Mary Street
Ilkeston
Derbyshire
DE7 8AB

Central Medical Services Ltd (Registered number: 07643110)

Balance Sheet
30 June 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,590,518 731,809

CURRENT ASSETS
Stocks 147,500 62,840
Debtors 5 1,281,475 934,574
Cash at bank and in hand 34,727 201,871
1,463,702 1,199,285
CREDITORS
Amounts falling due within one year 6 1,876,090 1,660,787
NET CURRENT LIABILITIES (412,388 ) (461,502 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,178,130

270,307

CREDITORS
Amounts falling due after more than one
year

7

(912,291

)

(318,191

)

PROVISIONS FOR LIABILITIES (69,871 ) (36,188 )
NET ASSETS/(LIABILITIES) 195,968 (84,072 )

CAPITAL AND RESERVES
Called up share capital 10 4 4
Retained earnings 195,964 (84,076 )
SHAREHOLDERS' FUNDS 195,968 (84,072 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Central Medical Services Ltd (Registered number: 07643110)

Balance Sheet - continued
30 June 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 7 March 2025 and were signed by:





S Wood - Director


Central Medical Services Ltd (Registered number: 07643110)

Notes to the Financial Statements
for the Year Ended 30 June 2024


1. STATUTORY INFORMATION

Central Medical Services Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


The figures in the financial statements are rounded to the nearest £1.

The company is not a member of a group and these financial statements therefore cover only the individual company.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes and is recognised when the relevant services have been provided.

Central Medical Services Ltd (Registered number: 07643110)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2024


2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery - 33% on cost
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 25% on reducing balance

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Central Medical Services Ltd (Registered number: 07643110)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Cash and cash equivalents
Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 62 (2023 - 59 ) .

Central Medical Services Ltd (Registered number: 07643110)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2024


4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and Motor
property machinery fittings vehicles Totals
£    £    £    £    £   
COST
At 1 July 2023 13,044 548,761 42,533 2,160,643 2,764,981
Additions 19,788 153,301 34,557 1,165,120 1,372,766
Disposals - - - (77,624 ) (77,624 )
At 30 June 2024 32,832 702,062 77,090 3,248,139 4,060,123
DEPRECIATION
At 1 July 2023 7,801 469,343 18,866 1,537,162 2,033,172
Charge for year 5,631 74,062 5,408 428,956 514,057
Eliminated on disposal - - - (77,624 ) (77,624 )
At 30 June 2024 13,432 543,405 24,274 1,888,494 2,469,605
NET BOOK VALUE
At 30 June 2024 19,400 158,657 52,816 1,359,645 1,590,518
At 30 June 2023 5,243 79,418 23,667 623,481 731,809

The net book value of tangible fixed assets includes £ 1,291,294 (2023 - £ 591,024 ) in respect of assets held under hire purchase contracts and finance leases.

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 728,344 602,683
Other debtors 855 3,575
Directors' current accounts 84,949 69,386
Corporation tax debtor 27,952 22,699
Accrued income 254,077 134,448
Prepayments 185,298 101,783
1,281,475 934,574

Central Medical Services Ltd (Registered number: 07643110)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2024


6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Advance from debt factor 320,706 426,829
Other loans 33,847 30,578
Hire purchase contracts and finance leases (see note 8)
392,174

383,452
Trade creditors 564,340 381,741
Corporation tax 46,753 55,864
Social security and other taxes 136,884 45,003
VAT 24,824 25,291
Credit card 14,559 20,615
Pension control 8,126 -
Deferred income 52,237 56,550
Accruals 281,640 234,864
1,876,090 1,660,787

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Other loans over 12 months 2,978 36,825
Hire purchase contracts and finance leases (see note 8)
909,313

281,366
912,291 318,191

8. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase contracts Finance leases
2024 2023 2024 2023
£    £    £    £   
Net obligations repayable:
Within one year 7,129 12,220 385,045 371,232
Between one and five years - 7,128 909,313 274,238
7,129 19,348 1,294,358 645,470

Non-cancellable operating leases
2024 2023
£    £   
Within one year 110,281 88,100
Between one and five years 232,074 107,048
342,355 195,148

Central Medical Services Ltd (Registered number: 07643110)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2024


9. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£    £   
Advance from debt factor 320,706 426,829
Hire purchase contracts and finance leases 1,301,487 664,818
1,622,193 1,091,647

The amounts owed under finance leases and hire purchase agreements are secured on the assets subject to the lease or agreement and in most instances by personal guarantee of the director.

Advances from debt factors are secured by debenture over the assets of the company and in part by personal guarantee of the director.

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
4 Ordinary (A to D) £1.00 4 4

11. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following loans (repayable on demand & interest free) to a director subsisted during the years ended 30 June 2024 and 30 June 2023:

2024 2023
£    £   
S Wood
Balance outstanding at start of year 69,386 57,592
Amounts advanced 20,563 11,794
Amounts repaid (5,000 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 84,949 69,386